Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Molecular Devices Introduces FLIPR Calcium 6 Assay Kits
Tuesday, April 23, 2013
Latest addition to the FLIPR Calcium range featuring exclusive fluorophore for assaying the most challenging, low-responding targets.

High Pressure IC Speeds Separations of Counter Ions in a Drug Tablet
Friday, April 19, 2013
New technical note on rapid separation and quantification of counter ion using Dionex ICS-5000+ HPIC system.

HµrelStaticDog™, Hµrel Corporation’s In Vitro Cell Culture of Canine (Dog) Liver Cells, to be Presented at Toxicology Conference
Thursday, April 11, 2013
Data highlight benefits of new tool for predicting drug toxicity in humans before clinical trials begin - important milestone in drug development evolution.

Randox Launches Three New ELISA Kits for the Detection of Z Drugs
Thursday, March 28, 2013
ELISA kits for the detection of Zopiclone, Zaleplon and Zolpidem in urine and blood specimens.

Gentronix Unveils New Corporate Identity and Website
Tuesday, March 26, 2013
Gentronix offers GreenScreen® HC and BlueScreen™ HC assays.

Thermo Scientific Introduces TriPlus 300 Headspace Autosampler at Pittcon 2013
Friday, March 22, 2013
New gas chromatography headspace autosampler features 120-vial sample tray and 18-vial incubation capacity for high-throughput capability.

Thermo Scientific Launches Next-Generation Trace Analysis Software at Pittcon 2013
Friday, March 22, 2013
TraceFinder streamlines routine quantitation, targeted screening and qualitative data review for chromatography, mass spectrometry instruments.

Bio-Rad Introduces New Bio-Plex Pro™ RBM Kidney Toxicity Panels
Thursday, March 14, 2013
The Bio-Plex Pro™ RBM human, rat, and canine kidney toxicity panels enable early detection and characterization of kidney toxicity and injury during drug development.

New 24-well RAFT Kit for Realistic 3D Cell Culture Models for Toxicology Research
Friday, March 08, 2013
Come and see this versatile 3D cell culture method on TAP’s Booth #1159 at SOT.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 655
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv